Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-Related Macular Degeneration: PIER Study Year 2

Title
Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-Related Macular Degeneration: PIER Study Year 2
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF OPHTHALMOLOGY
Volume 150, Issue 3, Pages 315-324.e1
Publisher
Elsevier BV
Online
2010-07-05
DOI
10.1016/j.ajo.2010.04.011

Ask authors/readers for more resources

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started